Safeguard Your Intellectual Property ®
SSJR has secured an additional $2 million bond from AstraZeneca, adding to an existing $60 million bond, to allow recovery of damages and costs sustained by SSJR client Apotex as a result of an injunction improvidently issued by the District Court. If the trial court’s recent decision that the AstraZeneca’s […]
Read MoreSSJR congratulates its client, Dr. Leonard Flom, on his induction in the U.S. National Inventors Hall of Fame. The Hall of Fame recognizes those whose work have had a major impact on society, the public welfare, and the progress of science. Dr. Flom is being recognized for his work in […]
Read MoreOn April 4, 2013, the District Court for the Southern District of New York dismissed, with prejudice, a patent infringement lawsuit that had been brought against SSJR’s client Monsieur Touton Selection, Ltd. (“Touton”). Touton was sued by Lamina Packing Innovations, LLC, for infringement of two patents related to laminated cartons […]
Read MoreSSJR’s trial team successfully defended its client Apotex against a claim of patent infringement brought by AstraZeneca regarding a generic version of AstraZeneca’s Pulmicort Respules. AstraZeneca filed suit against Apotex and several other generic drug manufacturers for infringement of two U.S. patents directed to methods of use and formulations of […]
Read MoreThe United States Court of Appeals for the Federal Circuit has granted a rehearing en banc in LIGHTING BALLAST CONTROL v. PHILIPS ELECTRONICS. The Federal Circuit is considering the continued viability of de novo appellate claim construction under Cybor Corp. v. FAS Techs., Inc., 138 F.3d 1448, 1454–55 (Fed.Cir.1998) and […]
Read MoreJoin our mailing list for regular updates.